Millennium Management’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-142,100
Closed -$16M 3203
2016
Q1
$16M Buy
142,100
+58,200
+69% +$6.05M 0.04% 579
2015
Q4
$9.12M Buy
+83,900
New +$9.6M 0.02% 973
2013
Q4
Sell
-2,600
Closed -$440K 3474
2013
Q3
$440K Buy
+2,600
New +$404K ﹤0.01% 2627

Other funds holding CLB

Millennium Management's CLB Position: Q1 2026 in Review

Millennium Management increased its Core Laboratories (CLB) stake by 65% in Q1 2026, buying an estimated $168K and bringing the position to 23,802 shares worth $400K. The position accounts for ﹤0.01% of the portfolio, ranked #4878.

Millennium Management first reported a position in CLB in Q4 2013 and has held it in 32 quarters since. The position peaked at $75.6M in Q2 2017. 190 funds tracked by Wall St. Rank hold CLB as of Q1 2026.

  • Millennium Management held 23,802 shares of Core Laboratories worth $400K as of Q1 2026.
  • Millennium Management bought 9,397 Core Laboratories shares in Q1 2026, an estimated $168K.
  • Core Laboratories made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #4878 holding.
  • Millennium Management first reported a position in Core Laboratories in Q4 2013 and has held it in 32 quarters since.
  • Millennium Management's Core Laboratories position peaked at $75.6M in Q2 2017.
  • 190 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.